FDA issues new safety alert on Reumofan Plus and Reumofan Plus Premium

The U.S. Food and Drug Administration today issued a new warning to consumers about the potential health risks of two products marketed as natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions. The products, Reumofan Plus and Reumofan Plus Premium, contain several potentially harmful active pharmaceutical ingredients that are not listed on the product labels.

Home | Copyright 2008-2024 FoodandDrugRecall.org